Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
A vaccine made of recombinant outer surface proteins from Borrelia burgdorferi (CDC1999).
Since the last update, we have not found any published data on its excretion in breast milk.
Its very high molecular weight makes its transfer to milk in significant quantities very unlikely.
Its low oral bioavailability would hinder its transfer to the infant’s plasma from ingested breast milk because, due to its protein nature, it degrades in the gastrointestinal tract, and is not absorbed.
This vaccine was withdrawn from sale in 2002, after only a few years of availability (FDA 2002) for reasons unrelated to its effectiveness (Kaaijk 2016, Aronowitz 2012).
Vaccines are compatible with breastfeeding, both those that are live attenuated microorganisms, as well as those that are dead, inactivated or those formed by parts of or toxoids of the same (Sachs 2013, CDC 2011).
With the exception of rubella, smallpox and yellow fever, live virus vaccines are not excreted in breast milk and do not cause problems in infants, except for yellow fever in children under 6 months (Sachs 2013, CDC 2011).
Breastfeeding can improve the antibody response of vaccines (CDC 2011).
Women who breastfeed can and should be protected with the recommended vaccines like other adults.
See below the information of this related product: